Literature DB >> 31625172

It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies.

Mark H Yazer1,2, Meghan Delaney3,4, Heidi Doughty5, Nancy M Dunbar6, Arwa Z Al-Riyami7, Darrell J Triulzi1,2, Jon F Watchko8, Erica M Wood9,10, Vered Yahalom11, Stephen P Emery12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31625172     DOI： 10.1111/trf.15569

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  5 in total

1.  The Evolution of Blood Product Use in Trauma Resuscitation: Change Has Come.

Authors:  Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2021-11-02       Impact factor: 3.747

2.  Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts.

Authors:  Willy Albert Flegel; Franz Friedrich Wagner; Diarmaid Padraig Ó Donghaile
Journal:  Transfusion       Date:  2020-05       Impact factor: 3.157

3.  Conservation of Rh negative Low Titer O Whole Blood (LTOWB) and the need for a national conversation to define its use in trauma transfusion protocols.

Authors:  Marla Troughton; Pampee P Young
Journal:  Transfusion       Date:  2021-03-29       Impact factor: 3.157

4.  The Norwegian blood preparedness project: A whole blood program including civilian walking blood banks for early treatment of patients with life-threatening bleeding in municipal health care services, ambulance services, and rural hospitals.

Authors:  Torunn Oveland Apelseth; Mirjana Arsenovic; Geir Strandenes
Journal:  Transfusion       Date:  2022-06-25       Impact factor: 3.337

5.  Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.

Authors:  Nicholas Crombie; Heidi A Doughty; Jonathan R B Bishop; Amisha Desai; Emily F Dixon; James M Hancox; Mike J Herbert; Caroline Leech; Simon J Lewis; Mark R Nash; David N Naumann; Gemma Slinn; Hazel Smith; Iain M Smith; Rebekah K Wale; Alastair Wilson; Natalie Ives; Gavin D Perkins
Journal:  Lancet Haematol       Date:  2022-03-07       Impact factor: 18.959
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.